6-35597399-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_004117.4(FKBP5):āc.514C>Gā(p.Leu172Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,461,120 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 32)
Exomes š: 0.0000014 ( 0 hom. )
Consequence
FKBP5
NM_004117.4 missense
NM_004117.4 missense
Scores
3
9
7
Clinical Significance
Conservation
PhyloP100: 5.09
Genes affected
FKBP5 (HGNC:3721): (FKBP prolyl isomerase 5) The protein encoded by this gene is a member of the immunophilin protein family, which play a role in immunoregulation and basic cellular processes involving protein folding and trafficking. This encoded protein is a cis-trans prolyl isomerase that binds to the immunosuppressants FK506 and rapamycin. It is thought to mediate calcineurin inhibition. It also interacts functionally with mature hetero-oligomeric progesterone receptor complexes along with the 90 kDa heat shock protein and P23 protein. This gene has been found to have multiple polyadenylation sites. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.821
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FKBP5 | NM_004117.4 | c.514C>G | p.Leu172Val | missense_variant | 6/11 | ENST00000357266.9 | NP_004108.1 | |
FKBP5 | NM_001145775.3 | c.514C>G | p.Leu172Val | missense_variant | 7/12 | NP_001139247.1 | ||
FKBP5 | NM_001145776.2 | c.514C>G | p.Leu172Val | missense_variant | 6/11 | NP_001139248.1 | ||
FKBP5 | NM_001145777.2 | c.514C>G | p.Leu172Val | missense_variant | 6/7 | NP_001139249.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FKBP5 | ENST00000357266.9 | c.514C>G | p.Leu172Val | missense_variant | 6/11 | 1 | NM_004117.4 | ENSP00000349811.3 | ||
FKBP5 | ENST00000536438.5 | c.514C>G | p.Leu172Val | missense_variant | 7/12 | 1 | ENSP00000444810.1 | |||
FKBP5 | ENST00000539068.5 | c.514C>G | p.Leu172Val | missense_variant | 6/11 | 1 | ENSP00000441205.1 | |||
FKBP5 | ENST00000542713.1 | c.514C>G | p.Leu172Val | missense_variant | 6/7 | 2 | ENSP00000442340.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 250268Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135326
GnomAD3 exomes
AF:
AC:
1
AN:
250268
Hom.:
AF XY:
AC XY:
1
AN XY:
135326
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461120Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726890
GnomAD4 exome
AF:
AC:
2
AN:
1461120
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
726890
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 26, 2024 | The c.514C>G (p.L172V) alteration is located in exon 7 (coding exon 5) of the FKBP5 gene. This alteration results from a C to G substitution at nucleotide position 514, causing the leucine (L) at amino acid position 172 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;.;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M;M;M
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N
REVEL
Pathogenic
Sift
Benign
T;T;T;T
Sift4G
Benign
T;T;T;T
Polyphen
D;D;D;.
Vest4
MutPred
Gain of methylation at R175 (P = 0.1333);Gain of methylation at R175 (P = 0.1333);Gain of methylation at R175 (P = 0.1333);Gain of methylation at R175 (P = 0.1333);
MVP
MPC
0.39
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at